Results 161 to 170 of about 2,368,347 (279)

Advances in Glaucoma Management and Intraocular Pressure Physiology

“Advances in Glaucoma Management and Intraocular Pressure Physiology” brings together a comprehensive collection of cutting-edge research on glaucoma, emphasizing both clinical and translational innovations.

core   +1 more source

The Association Between Regional Macula Vessel Density and Central Visual Field Damage in Advanced Glaucoma Eyes. [PDF]

J Glaucoma, 2022
Ghahari E, Bowd C, Zangwill LM, Proudfoot JA, Penteado RC, Kyung H, Hou H, Moghimi S, Weinreb RN.   +8 more
europepmc   +1 more source

Rethinking diabetic retinopathy: Homeostatic mechanisms for retinal clearance

Diabetic Medicine, EarlyView.
In the healthy retina, balanced production and clearance of metabolic waste and fluid maintain retinal homeostasis and normal visual function. Diabetes disrupts this balance, increasing the accumulation of metabolic waste products, including advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs), while impairing waste and ...
Karis Little, Judith Lechner, Giulia De Rossi, Tara Cullen, Jennifer Perais, Eleni Beli, Noemi Lois, Alan W. Stitt   +7 more
wiley   +1 more source

Infographic of primary trabeculectomy for advanced glaucoma study (TAGS). [PDF]

Eye (Lond), 2022
Fang CEH, Mathew RG, Henein C.
europepmc   +1 more source

Neuropsychiatric Outcomes Associated With GLP‐1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptors are expressed in brain regions governing mood, reward and stress, yet the neuropsychiatric effects of GLP‐1 receptor agonist (GLP‐1 RA) therapy remain poorly characterized. We estimated associations between GLP‐1 RA use and neuropsychiatric disorders and variation by obesity status and treatment ...
Seo Hyon Baik, Fitsum Baye, Haotian Xian, Kin Wah Fung, Clement J. McDonald   +4 more
wiley   +1 more source

Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma. [PDF]

Br J Ophthalmol, 2022
Kernohan A, Homer T, Shabaninejad H, King AJ, Hudson J, Fernie G, Azuara-Blanco A, Burr J, Sparrow JM, Garway-Heath D, Barton K, Norrie J, Maclennan G, Vale L.   +13 more
europepmc   +1 more source

Charting the course of Sjögren's disease: A historical analysis of scientific progress

European Journal of Oral Sciences, EarlyView.
Abstract Sjögren's disease (SjD) bears the name of the Swedish ophthalmologist Henrik Sjögren. His 1933 doctoral thesis on keratoconjunctivitis sicca ignited interest, yet much remains under debate. SjD is an autoimmune disorder that primarily affects the exocrine glands, particularly the salivary and lacrimal glands, leading to a dryness of the eyes ...
Diego Ustárroz Cantali, Fabiola Reis de Oliveira, Denise Cantarelli Machado, Moisés Evandro Bauer   +3 more
wiley   +1 more source

Evaluation of the Correlation between Regional Retinal Ganglion Cell Damage and Visual Field Sensitivity in Patients with Advanced Glaucoma. [PDF]

J Clin Med, 2022
Rezkallah A, Douma I, Bonjour M, Mathis T, Kodjikian L, Denis P.   +5 more
europepmc   +1 more source

Structural, Vascular, and Functional Correlations in Advanced Glaucoma. [PDF]

J Curr Ophthalmol
Özata Gündoğdu K, Özkan Aksoy N, Mutlu MN.   +2 more
europepmc   +1 more source

Reply to Letter to the Editor: The Association Between Regional Macula Vessel Density and Central Visual Field Damage in Advanced Glaucoma Eyes. [PDF]

J Glaucoma, 2022
Ghahari E, Moghimi S, Weinreb RN.
europepmc   +1 more source